Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,165 | 4 | 50.1% |
| Travel and Lodging | $13,153 | 8 | 46.5% |
| Food and Beverage | $951.02 | 13 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $16,338 | 20 | $0 (2024) |
| Amicus Therapeutics, Inc. | $11,775 | 4 | $0 (2024) |
| Shire North American Group Inc | $156.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,791 | 5 | Amicus Therapeutics, Inc. ($11,775) |
| 2023 | $2,118 | 2 | GENZYME CORPORATION ($2,118) |
| 2022 | $3,297 | 1 | GENZYME CORPORATION ($3,297) |
| 2019 | $10,942 | 15 | GENZYME CORPORATION ($10,786) |
| 2017 | $120.79 | 2 | GENZYME CORPORATION ($120.79) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | Amicus Therapeutics, Inc. | GALAFOLD (Drug) | Travel and Lodging | Cash or cash equivalent | $10,507.30 | General |
| Category: FABRY DISEASE | ||||||
| 09/20/2024 | Amicus Therapeutics, Inc. | GALAFOLD (Drug) | Travel and Lodging | Cash or cash equivalent | $743.09 | General |
| Category: FABRY DISEASE | ||||||
| 09/20/2024 | Amicus Therapeutics, Inc. | GALAFOLD (Drug) | Travel and Lodging | Cash or cash equivalent | $351.05 | General |
| Category: FABRY DISEASE | ||||||
| 09/20/2024 | Amicus Therapeutics, Inc. | GALAFOLD (Drug) | Food and Beverage | In-kind items and services | $173.12 | General |
| Category: FABRY DISEASE | ||||||
| 05/17/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Oncology | ||||||
| 12/02/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Consulting Fee | Cash or cash equivalent | $2,048.00 | General |
| Category: Genetic Disease | ||||||
| 02/25/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $70.26 | General |
| 12/02/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $3,297.00 | General |
| Category: Genetic Disease | ||||||
| 08/03/2019 | GENZYME CORPORATION | FABRAZYME (Drug) | Consulting Fee | Cash or cash equivalent | $3,570.00 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 08/03/2019 | GENZYME CORPORATION | FABRAZYME (Drug) | Travel and Lodging | In-kind items and services | $348.00 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 08/03/2019 | GENZYME CORPORATION | FABRAZYME (Drug) | Travel and Lodging | In-kind items and services | $335.00 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 08/03/2019 | GENZYME CORPORATION | FABRAZYME (Drug) | Travel and Lodging | In-kind items and services | $297.72 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 08/03/2019 | GENZYME CORPORATION | FABRAZYME (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 08/03/2019 | GENZYME CORPORATION | FABRAZYME (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 08/03/2019 | GENZYME CORPORATION | FABRAZYME (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 05/22/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 05/22/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | Travel and Lodging | In-kind items and services | $343.61 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 05/22/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | Travel and Lodging | In-kind items and services | $226.86 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 05/22/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | Food and Beverage | In-kind items and services | $116.67 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 05/22/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | Food and Beverage | In-kind items and services | $64.62 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 05/22/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | Food and Beverage | In-kind items and services | $41.54 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 05/22/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | Food and Beverage | In-kind items and services | $41.54 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 04/05/2019 | Shire North American Group Inc | — | Food and Beverage | In-kind items and services | $156.00 | General |
| 02/15/2017 | GENZYME CORPORATION | DISEASE STATE (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| 01/24/2017 | GENZYME CORPORATION | FABRY-DISEASE (Drug) | Food and Beverage | In-kind items and services | $100.01 | General |
About Dr. Damara Ortiz, M.D
Dr. Damara Ortiz, M.D is a Clinical Genetics (M.D.) healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2011. The National Provider Identifier (NPI) number assigned to this provider is 1811277130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Damara Ortiz, M.D has received a total of $28,269 in payments from pharmaceutical and medical device companies, with $11,791 received in 2024. These payments were reported across 25 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($14,165).
Practice Information
- Specialty Clinical Genetics (M.D.)
- Other Specialties Student in an Organized Health Care Education/Training Program, Pediatrics
- Location Pittsburgh, PA
- Active Since 08/17/2011
- Last Updated 09/16/2025
- Taxonomy Code 207SG0201X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811277130
Products in Payments
- GALAFOLD (Drug) $11,775
- LUMIZYME (Drug) $6,085
- FABRAZYME (Drug) $4,701
- FABRAZYME (Biological) $3,297
- CERDELGA (Drug) $2,048
- FABRY-DISEASE (Drug) $100.01
- DISEASE STATE (Drug) $20.78
- SARCLISA (Biological) $16.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Genetics (M.D.) Doctors in Pittsburgh
Dr. Jirair Bedoyan, M.d.,Ph.d, M.D.,PH.D
Clinical Genetics (M.D.) — Payments: $23,918
Uta Lichter-Konecki, Md, MD
Clinical Genetics (M.D.) — Payments: $11,534
Raelynn Forsyth, M.d, M.D
Clinical Genetics (M.D.) — Payments: $7,001
Matthew Shanahan, M.d, M.D
Clinical Genetics (M.D.) — Payments: $353.33
Dr. Suneeta Madan-Khetarpal, M.d, M.D
Clinical Genetics (M.D.) — Payments: $174.81
Dr. Michael Bashford, M.d, M.D
Clinical Genetics (M.D.) — Payments: $13.23